top of page

Facts and Statistics on Brain Cancer

Brain cancer encompasses a diverse group of tumors originating in the brain and central nervous system (CNS). It affects thousands of people worldwide each year, presenting significant challenges in diagnosis, treatment, and research. Here are some key facts and statistics to highlight the impact of brain cancer and the ongoing efforts to combat it.

​

General Facts

​

  • Brain Tumor Types: There are over 120 types of brain and central nervous system tumors, which are classified based on the cell type from which they originate, their location, and whether they are benign or malignant.

  • Primary vs. Secondary: Primary brain tumors originate in the brain, while secondary (or metastatic) brain tumors result from cancer spreading from another part of the body to the brain.

  • Age Impact: Brain tumors can occur at any age, but certain types are more common in children or adults. For example, medulloblastomas are most common in children, while glioblastomas are more prevalent in adults.

  • Cell Origin: Brain tumors can originate from any type of cell within the brain or surrounding structures, including neurons, glial cells, lymphatic tissue, blood vessels, and cranial nerves.

  • Childhood Cancer: Brain tumors are the second most common form of cancer in children, following leukemia, and the most common form of solid tumors in pediatric patients.

  • Gender Differences: Certain types of brain tumors are more prevalent in one gender than the other; for example, meningiomas are more common in women, while glioblastomas are more common in men.

  • Genetic Research: Ongoing genetic and molecular research is uncovering specific mutations and alterations that can drive the development of brain tumors, paving the way for targeted therapies.

  • Environmental Factors: While definitive environmental causes of brain tumors are not conclusively proven, ongoing research is investigating potential links with exposure to certain chemicals, electromagnetic fields, and viruses.

  • Symptom Variability: The symptoms of a brain tumor depend not only on the tumor's size but also on its location, as different parts of the brain control different functions. This variability can sometimes delay diagnosis.

  • Technological Advances in Diagnosis: Innovations in imaging technology, such as functional MRI and PET scans, have significantly improved the ability to diagnose brain tumors accurately and to plan treatment strategies.

  • Surgical Techniques: Advances in neurosurgery, such as awake brain surgery and neuronavigation, have improved the precision of tumor removal while minimizing damage to healthy brain tissue.

  • Quality of Life Focus: Increasing emphasis is being placed not only on extending life but also on improving the quality of life for brain tumor patients, addressing neurological and cognitive function, mental health, and overall well-being.

  • Global Incidence Variability: The incidence of brain tumors varies globally, with differences attributed to genetic, environmental, and lifestyle factors, as well as disparities in access to healthcare and diagnostic capabilities.

Statistics

​

  • Incidence: According to the World Health Organization (WHO), the global incidence of brain tumors is approximately 3 cases per 100,000 people annually.

  • Prevalence: In the United States, an estimated 700,000 people are living with a primary brain tumor, and tens of thousands of new cases are diagnosed each year.

  • Survival Rates: Survival rates vary significantly depending on the type of tumor, age at diagnosis, and overall health of the patient. For instance, the 5-year relative survival rate for glioblastoma, one of the most aggressive types, is around 7%, whereas it is much higher for patients with meningioma, a typically benign tumor.

  • Research and Funding: Brain cancer research receives funding from various sources, including government agencies, non-profit organizations, and private institutions. However, it is considered underfunded compared to other cancers when considering its mortality rate and impact on life quality.

  • Childhood Brain Cancer: Brain tumors are the second most common type of cancer in children under age 15, following leukemia. Approximately 4,000 new cases are diagnosed in children and adolescents in the United States each year.

  • Gender Differences: Males are slightly more likely to develop brain tumors than females, with certain types of tumors, such as glioblastomas, showing a higher prevalence in men.

  • 5-Year Survival Rate for Children: The overall 5-year survival rate for children with brain tumors is about 74%, which varies significantly based on the type of tumor and other factors.

  • Genetic Research Funding: The National Brain Tumor Society reports that genetic and molecular research into brain tumors has increased, leading to the identification of potential new treatment targets.

  • Rare Tumor Incidence: Some brain tumors are extremely rare, with incidences of less than 1 per 1,000,000 people annually. These include tumors like pineoblastomas and primary CNS sarcomas.

  • Increase in Glioblastoma Incidence: The incidence of glioblastoma, the most aggressive and common form of malignant brain tumor in adults, has increased over the past few decades, now accounting for about 15% of all primary brain tumors.

  • Survival Rate Disparities: The 5-year survival rate for brain cancer varies widely among racial and ethnic groups, with disparities in access to care and treatment outcomes. For example, survival rates tend to be lower in African American patients compared to Caucasian patients for certain types of brain tumors.

  • Economic Impact: The economic burden of brain tumors is substantial, with the average cost of treatment for malignant brain tumor patients significantly higher than for many other types of cancer, largely due to the complexity of treatment and long-term care needs.

  • Clinical Trials Participation: Less than 5% of adults with brain cancer participate in clinical trials, which is a challenge for advancing research and developing new treatments.

  • Impact of COVID-19 on Treatment: The COVID-19 pandemic has impacted cancer care globally, including delays in diagnosis and treatment for brain cancer patients, which may affect survival rates and outcomes in the long term.

Risk Factors and Prevention

​

  • Risk Factors: The exact causes of most brain tumors are unknown. However, certain genetic conditions (such as Neurofibromatosis, Tuberous Sclerosis) and exposure to ionizing radiation are established risk factors.

  • Prevention: There are no proven strategies to prevent brain cancer, but reducing exposure to known risk factors may lower risk.
     

Symptoms and Diagnosis

​

  • Common Symptoms: Symptoms of brain tumors vary but may include headaches, seizures, vision or speech changes, behavioral or cognitive changes, and coordination problems.

  • Diagnostic Tools: Diagnosis typically involves neurological exams, imaging tests (MRI, CT scans), and biopsy for histological examination.
     

Treatment and Care

​

  • Treatment Options: Treatment depends on the tumor type, size, location, and patient's overall health, including surgery, radiation therapy, chemotherapy, targeted therapy, and clinical trials.

  • Innovations in Treatment: Advances in medical research, such as immunotherapy, precision medicine, and improved surgical techniques, offer new hope for better outcomes and quality of life for patients.
     

Impact on Quality of Life

​

  • Rehabilitation Needs: Many brain tumor patients require rehabilitation services, including physical therapy, occupational therapy, speech therapy, and psychological support, to address the side effects of the tumor and its treatment.

  • Support Networks: Support from healthcare professionals, support groups, and community resources is crucial for patients and their families to navigate the challenges of brain cancer.

bottom of page